| EMBECTA CORP. DL-,01 |
| USA |
| Gesundheit |
| US29082K1051 / A3DGNE |
| JX7 (Frankfurt) / EMBC (NASDAQ) |
| FRA:JX7, ETR:JX7, JX7:GR, NASDAQ:EMBC |
| - |
| https://www.embecta.com/ |
|
Embecta Corporation is a dynamic player in the healthcare industry, primarily focused on producing advanced medical devices. Its chief function is to innovate and manufacture devices related to diabetes care, addressing both individual and clinical n..
>Volltext.. |
| 452.64 Mio. EUR |
| 1470.24 Mio. EUR |
| 933.54 Mio. EUR |
| 344.3 Mio. EUR |
| 120.62 Mio. EUR |
| 2.06 EUR |
| 1219.39 Mio. EUR |
| 176.73 Mio. EUR |
| 185.2 Mio. EUR |
| 0.87 |
| -14.09% |
| 111.26% |
| 0.51 EUR |
| 7% |
| 6.99% |
| 27.02.26 - 0.12693€ 05.12.25 - 0.128805€ >weitere anzeigen... |
| - |
| EMBECTA |
| 01.04.26 |
|
||||
|
||||
|
||||
|